These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20647805)

  • 21. Afelimomab-another therapeutic option in sepsis therapy?
    Grass G; Neugebauer EA
    Crit Care Med; 2004 Nov; 32(11):2343-4. PubMed ID: 15640652
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential organ failure assessment score as the determinant of outcome for patients with severe sepsis.
    Vosylius S; Sipylaite J; Ivaskevicius J
    Croat Med J; 2004 Dec; 45(6):715-20. PubMed ID: 15578805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipopolysaccharide binding protein in a surgical intensive care unit: a marker of sepsis?
    Sakr Y; Burgett U; Nacul FE; Reinhart K; Brunkhorst F
    Crit Care Med; 2008 Jul; 36(7):2014-22. PubMed ID: 18552695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High C-reactive protein and low cholesterol levels are prognostic markers of survival in severe sepsis.
    Memiş D; Gursoy O; Tasdogan M; Süt N; Kurt I; Türe M; Karamanlioğlu B
    J Clin Anesth; 2007 May; 19(3):186-91. PubMed ID: 17531726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
    Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
    Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activated protein C in severe sepsis--joyful news].
    Møller K; Skinhøj P
    Ugeskr Laeger; 2001 Mar; 163(12):1713. PubMed ID: 11284413
    [No Abstract]   [Full Text] [Related]  

  • 28. From mice to men: systematic reviews of animal data could make sepsis trials safer and more productive.
    Pitts LR; Simpson SQ
    Crit Care Med; 2010 Dec; 38(12):2420-2. PubMed ID: 21088514
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock.
    McLean AS; Huang SJ; Hyams S; Poh G; Nalos M; Pandit R; Balik M; Tang B; Seppelt I
    Crit Care Med; 2007 Apr; 35(4):1019-26. PubMed ID: 17334249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sublingual capnometry versus traditional markers of tissue oxygenation in critically ill patients.
    Marik PE; Bankov A
    Crit Care Med; 2003 Mar; 31(3):818-22. PubMed ID: 12626990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antithrombin levels, morbidity, and mortality in a surgical intensive care unit.
    Sakr Y; Reinhart K; Hagel S; Kientopf M; Brunkhorst F
    Anesth Analg; 2007 Sep; 105(3):715-23. PubMed ID: 17717229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear factor-kappaB: is it a therapeutic target for the adjuvant treatment of sepsis?
    Fink MP
    Crit Care Med; 2003 Sep; 31(9):2400-2. PubMed ID: 14501975
    [No Abstract]   [Full Text] [Related]  

  • 33. [Sepsis score in surgical intensive care medicine].
    Reist K; Hilfiker O; Stepniewski MS; Heinzer I; Berchtold W; Reist U; Bürgi U; Aeberhard P; Bürgi W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Nov; 31(9):556-62. PubMed ID: 9063920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsis.
    Barochia AV; Cui X; Natanson C; Eichacker PQ
    Crit Care Med; 2010 Jan; 38(1):306-8. PubMed ID: 20023474
    [No Abstract]   [Full Text] [Related]  

  • 35. Biomarkers for sepsis: PERSEVERE to the bitter end.
    Nadel S
    Pediatr Crit Care Med; 2011 Mar; 12(2):225-6. PubMed ID: 21646948
    [No Abstract]   [Full Text] [Related]  

  • 36. Biomarkers of sepsis can predict death.
    Hill R
    Bioanalysis; 2013 Sep; 5(18):2223. PubMed ID: 24053236
    [No Abstract]   [Full Text] [Related]  

  • 37. Interleukin-6 concentrations in neonatal sepsis.
    Onal EE; Kitapçi F; Dilmen U; Adam B
    Lancet; 1999 Jan; 353(9148):239-40. PubMed ID: 9923903
    [No Abstract]   [Full Text] [Related]  

  • 38. Year in review 2013: Critical Care--sepsis.
    de Montmollin E; Annane D
    Crit Care; 2014 Oct; 18(5):578. PubMed ID: 25673430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Personalized medicine in sepsis: the coming of age.
    Christaki E
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):645-7. PubMed ID: 23879604
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical research in the critical care environment.
    Berry DA
    Crit Care Med; 1993 Sep; 21(9 Suppl):S400-2. PubMed ID: 8365257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.